Table 2: Use, Considerations, and Three-Month Follow Up of Breast Cancer Risk-Reducing Strategies.
Risk reducing strategies (endocrine risk reduction, decreasing alcohol, increasing exercise, etc.) that participants are already doing before using BHD, and risk reducing strategies that participants are considering after using BHD, obtained from immediate feedback survey with N = 318 respondents. And risk reducing strategies that they pursued three months later, obtained from three month follow up survey with N=109 respondents.
| High Risk N = 221 (%) |
Highest Risk N = 97 (%) |
Total N = 318 (%) |
Pearson’s Chi Squared Test (high- vs. highest-risk participants) |
|
|---|---|---|---|---|
| Already doing risk reducing activities | ||||
| Medication | 7 (3.2%) | 8 (8.2%) | 15 (4.7%) | p = 0.09 |
| Decrease alcohol | 74 (33.5%) | 49 (50.5%)≠ | 123 (38.7%) | p = 0.006 |
| Increase exercise | 133 (60.2%) | 66 (68%) | 199 (62.6%) | p = 0.84 |
| Lose weight | 82 (37.1%) | 45 (46.4%) | 127 (39.9%) | N/A |
| Other | 14 (6.3%) | 12 (12.4%) | 26 (8.2%) | N/A |
| Nothing | 52 (23.5%) | 13 (13.4%) | 65 (20.4%) | N/A |
| Considering risk reducing activities (immediately after using tool) | ||||
| Medication | 72 (32.6%) | 38 (39.2%) | 110 (34.6%) | p = 0.31 |
| Decrease alcohol | 33 (14.9%) | 14 (14.4%) | 47 (14.8%) | p = 1 |
| Increase exercise | 76 (34.4%) | 22 (22.7%) | 98 (30.8%) | p = 0.051 |
| Lose weight | 65 (29.4%) | 17 (17.5%) | 82 (25.8%) | N/A |
| Other | 14 (6.3%) | 3 (3.1%) | 17 (5.3%) | N/A |
| Nothing | 42 (19%) | 22 (22.7%) | 64 (20.1%) | N/A |
| Highest Risk (N = 72) |
Highest Risk (N = 37) |
Total (N = 109) |
||
| Risk reducing activities 3 months after using tool | ||||
| Medication | 7 (9.7%) | 5 (13.5%) | 12 (11%) | p = 0.78 |
| Decrease alcohol | 26 (36.1%) | 16 (43.2%) | 42 (38.5%) | p = 0.6 |
| Increase exercise | 34 (47.2%) | 19 (51.4%) | 53 (48.6%) | p = 0.84 |
| Diet | 47 (65.3%) | 26 (70.3%) | 73 (67%) | N/A |
| Would like support services (3 months after using tool) | 30 (41.7%) | 17 (45.9%) | 47 (43.1%) | N/A |
Notes:
% calculated is out of total who either considered endocrine risk reduction, or the total who did not consider endocrine risk reduction from feedback survey response
statistical significance between high- and highest-risk group
High risk = WISDOM screening assignment recommendation yearly, highest risk = WISDOM screening assignment every 6 months (alternating mammography and MRI). Only high- and highest-risk participants receive a breast health specialist consult with the BHD tool. The low-risk participants however have access to the tool to look through on their own.